223 related articles for article (PubMed ID: 21105197)
21. [Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection].
Bao YD; Zhang H; Dong L; Jiang KW; Ye YJ; Wang S; Zhou J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):145-152. PubMed ID: 33508920
[No Abstract] [Full Text] [Related]
22. Clinical Outcome of Doublet and Triplet Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer.
Kim JS; Kang SH; Moon HS; Sung JK; Jeong HY; Sul JY
Korean J Gastroenterol; 2016 Nov; 68(5):245-252. PubMed ID: 27871160
[TBL] [Abstract][Full Text] [Related]
23. [Timing of surgery after neoadjuvant chemotherapy for advanced gastric cancer].
Hu X
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Jun; 16(6):509-12. PubMed ID: 23801199
[TBL] [Abstract][Full Text] [Related]
24. [Meta-analysis of gastric stump cancer after gastrectomy for gastric cancer].
Li Y; Gao Z; Zhao X; Wang B; Ye Y; Wang S; Jiang K
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 May; 21(5):569-577. PubMed ID: 29774941
[TBL] [Abstract][Full Text] [Related]
25. Neoadjuvant chemotherapy with S-1 and CDDP in advanced gastric cancer.
Kochi M; Fujii M; Kanamori N; Kaiga T; Takahashi T; Kobayashi M; Takayama T
J Cancer Res Clin Oncol; 2006 Dec; 132(12):781-5. PubMed ID: 16804723
[TBL] [Abstract][Full Text] [Related]
26. Neoadjuvant chemoradiotherapy followed by D2 gastrectomy in locally advanced gastric cancer.
Kim MS; Lim JS; Hyung WJ; Lee YC; Rha SY; Keum KC; Koom WS
World J Gastroenterol; 2015 Mar; 21(9):2711-8. PubMed ID: 25759540
[TBL] [Abstract][Full Text] [Related]
27. Impact of Neoadjuvant Chemotherapy Among Patients with Pancreatic Fistula After Gastrectomy for Advanced Gastric Cancer.
Kosaka T; Akiyama H; Makino H; Kimura J; Takagawa R; Ono HA; Kunisaki C; Endo I
Anticancer Res; 2016 Apr; 36(4):1773-7. PubMed ID: 27069158
[TBL] [Abstract][Full Text] [Related]
28. A comparison between triplet and doublet chemotherapy in improving the survival of patients with advanced gastric cancer: a systematic review and meta-analysis.
Guo X; Zhao F; Ma X; Shen G; Ren D; Zheng F; Du F; Wang Z; Ahmad R; Yuan X; Zhao J; Zhao J
BMC Cancer; 2019 Nov; 19(1):1125. PubMed ID: 31747911
[TBL] [Abstract][Full Text] [Related]
29. [Clinical features and prognosis analysis of 21 gastric cancer patients with pathological complete response after neoadjuvant chemotherapy].
Peng L; Yang W; Zhang Z; Liu H; Hua Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Oct; 20(10):1168-1173. PubMed ID: 29130233
[TBL] [Abstract][Full Text] [Related]
30. [Prognostic value of the tumor deposit in N0 gastric cancer by propensity score matching analysis].
Zhi C; Yang W; Li N; Zhang Z; Hua Y; Liu H
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):172-179. PubMed ID: 30799540
[TBL] [Abstract][Full Text] [Related]
31. [Neoadjuvant chemotherapy for patients with positive cytology from advanced gastric cancer].
Nakagawa S; Nashimoto A; Yabusaki H
Gan To Kagaku Ryoho; 2006 Nov; 33(12):1774-6. PubMed ID: 17212104
[TBL] [Abstract][Full Text] [Related]
32. Survival Benefit of Neoadjuvant Chemotherapy with S-1 Plus Docetaxel for Locally Advanced Gastric Cancer: A Propensity Score-Matched Analysis.
Kano M; Hayano K; Hayashi H; Hanari N; Gunji H; Toyozumi T; Murakami K; Uesato M; Ota S; Matsubara H
Ann Surg Oncol; 2019 Jun; 26(6):1805-1813. PubMed ID: 30977014
[TBL] [Abstract][Full Text] [Related]
33. Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial.
Fujitani K; Yang HK; Mizusawa J; Kim YW; Terashima M; Han SU; Iwasaki Y; Hyung WJ; Takagane A; Park DJ; Yoshikawa T; Hahn S; Nakamura K; Park CH; Kurokawa Y; Bang YJ; Park BJ; Sasako M; Tsujinaka T;
Lancet Oncol; 2016 Mar; 17(3):309-318. PubMed ID: 26822397
[TBL] [Abstract][Full Text] [Related]
34. Neoadjuvant chemotherapy
Li Y; Ma FH; Xue LY; Tian YT
World J Gastroenterol; 2020 Feb; 26(8):818-827. PubMed ID: 32148379
[TBL] [Abstract][Full Text] [Related]
35. Trends in the use and impact of neoadjuvant chemotherapy on perioperative outcomes for resected gastric cancer: Evidence from the American College of Surgeons National Cancer Database.
Greenleaf EK; Hollenbeak CS; Wong J
Surgery; 2016 Apr; 159(4):1099-112. PubMed ID: 26704785
[TBL] [Abstract][Full Text] [Related]
36. Correlation of pathological complete response with survival after neoadjuvant chemotherapy in gastric or gastroesophageal junction cancer treated with radical surgery: A meta-analysis.
Li Z; Shan F; Wang Y; Zhang Y; Zhang L; Li S; Jia Y; Xue K; Miao R; Li Z; Ji J
PLoS One; 2018; 13(1):e0189294. PubMed ID: 29370182
[TBL] [Abstract][Full Text] [Related]
37. Neoadjuvant chemotherapy in locally advanced colon cancer: a systematic review and meta-analysis.
Gosavi R; Chia C; Michael M; Heriot AG; Warrier SK; Kong JC
Int J Colorectal Dis; 2021 Oct; 36(10):2063-2070. PubMed ID: 33945007
[TBL] [Abstract][Full Text] [Related]
38. Does neoadjuvant chemotherapy improve outcomes for patients with gastric cancer?
Misra S; Pedroso FE; DiPasco PJ; Solomon NL; Gennis E; Franceschi D; Ardalan B; Koniaris LG
J Surg Res; 2012 Dec; 178(2):623-31. PubMed ID: 22682528
[TBL] [Abstract][Full Text] [Related]
39. [T-downstaging after neoadjuvant chemotherapy in locally advanced gastric carcinoma].
Persiani R; D'Ugo D; Biondi A; Rausei S; Vigorita V; Zoccali M; Picciocchi A
Suppl Tumori; 2005; 4(3):S88. PubMed ID: 16437922
[TBL] [Abstract][Full Text] [Related]
40. [Survival analysis of gastric cancer cases with pathological complete response received neoadjuvant chemotherapy].
Zhang Y; Peng Z; Chen L
Zhonghua Yi Xue Za Zhi; 2016 May; 96(20):1582-4. PubMed ID: 27266687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
